Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Autonomic nervous system imbalance, Bone pain, Burning sensation, Cyanosis, Electric shock sensation
Clinical narrative: Nerve/vein pain bottom of left foot; Nerve/vein pain bottom of left foot; unable to walk for 2 days; Burning backs of legs, like shards of glass in veins, sometimes like chemical acid feeling; hard rigid muscles; Burning around neck veins; Pulsating temple veins; Bulging veins in feet; Electrical shock zap sensations in left leg; Spasms leg muscles; Sternum pain and tenderness; Sensation backs of legs would explode from pressure; Hamstring area severe nerve pain; Swelling/edema legs; Swelling/edema legs; Sensation of pinching in and rubber band feeling around leg muscles; Buttock pain both sides; Tachycardia; Livedo reticularis on legs and cyanosis of feet; Livedo reticularis on legs and cyanosis of feet; diagnosis - suspected small fiber neuropathy and autonomic dysfunction; diagnosis - suspected small fiber neuropathy and autonomic dysfunction; dose 1,  Drug Start date : 31Aug2021/dose 2, Drug Start date : 12Oct2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Oct2021 at 16:00 as dose 2, single (Lot number: FE3590) at the age of 42 years, in left arm for covid-19 immunization. The patient's relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 1,SINGLE, Lot No: EW0173, Arm Left,  12:00 PM), administration date: 31Aug2021, when the patient was 42-year-old, for COVID-19 immunization, reaction(s): "Noticeable heart beat in stomach", "Deep pain in hamstring area", "Sciatic pain", "Pain/tender back of head"; BNT162b2 (Dose Number: 1,SINGLE, Lot No: EW0173, Arm Left,  12:00 PM), administration date: 31Aug2021, when the patient was 42--old, for COVID-19 immunization, reaction(s): "Chest rash". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 12Oct2021, outcome "unknown", described as "dose 1,  Drug Start date : 31Aug2021/dose 2, Drug Start date : 12Oct2021"; VEIN DISORDER (non-serious) with onset 13Oct2021, outcome "unknown", described as "Bulging veins in feet"; NECK PAIN (non-serious) with onset 13Oct2021, outcome "unknown", described as "Burning around neck veins"; BURNING SENSATION (non-serious) with onset 13Oct2021, outcome "unknown", described as "Burning backs of legs, like shards of glass in veins, sometimes like chemical acid feeling"; MUSCULOSKELETAL PAIN (non-serious) with onset 13Oct2021, outcome "unknown", described as "Buttock pain both sides"; ELECTRIC SHOCK SENSATION (non-serious) with onset 13Oct2021, outcome "unknown", described as "Electrical shock zap sensations in left leg"; NEURALGIA (non-serious) with onset 13Oct2021, outcome "unknown", described as "Hamstring area severe nerve pain"; LIVEDO RETICULARIS (non-serious), CYANOSIS (non-serious) all with onset 13Oct2021, outcome "unknown" and all described as "Livedo reticularis on legs and cyanosis of feet"; PAIN IN EXTREMITY (non-serious), NEURALGIA (non-serious) all with onset 13Oct2021, outcome "unknown" and all described as "Nerve/vein pain bottom of left foot"; SENSATION OF BLOOD FLOW (non-serious) with onset 13Oct2021, outcome "unknown", described as "Pulsating temple veins"; LIMB DISCOMFORT (non-serious) with onset 13Oct2021, outcome "unknown", described as "Sensation backs of legs would explode from pressure"; MUSCLE DISCOMFORT (non-serious) with onset 13Oct2021, outcome "unknown", described as "Sensation of pinching in and rubber band feeling around leg muscles"; MUSCLE SPASMS (non-serious) with onset 13Oct2021, outcome "unknown", described as "Spasms leg muscles"; BONE PAIN (non-serious) with onset 13Oct2021, outcome "unknown", described as "Sternum pain and tenderness"; PERIPHERAL SWELLING (non-serious), OEDEMA PERIPHERAL (non-serious) all with onset 13Oct2021, outcome "unknown" and all described as "Swelling/edema legs"; TACHYCARDIA (non-serious) with onset 13Oct2021, outcome "unknown"; SMALL FIBRE NEUROPATHY (non-serious), AUTONOMIC NERVOUS SYSTEM IMBALANCE (non-serious) all with onset 13Oct2021, outcome "unknown" and all described as "diagnosis - suspected small fiber neuropathy and autonomic dysfunction"; MUSCLE RIGIDITY (non-serious) with onset 13Oct2021, outcome "unknown", described as "hard rigid muscles"; GAIT INABILITY (non-serious) with onset 13Oct2021, outcome "recovered" (15Oct2021), described as "unable to walk for 2 days". Sender's Comments: Linked Report(s) : US-PFIZER INC-202200851441 same patient/ drug, different dose/event;